Le Lézard
Classified in: Health
Subject: CCA

Nuvasive Announces Conference Call And Webcast Of Third Quarter 2017 Results

SAN DIEGO, Oct. 5, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will release its third quarter 2017 earnings results on Tuesday, October 24, 2017 after the close of the market.

NuVasive Logo

NuVasive will hold a conference call on Tuesday, October 24, 2017 at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the third quarter 2017. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers. A live webcast of the conference call will be available online from the Investor Relations page of the Company's website at www.nuvasive.com.

After the live webcast, the call will remain available on NuVasive's website through November 21, 2017. In addition, a telephone replay of the call will be available until October 31, 2017. The replay dial-in numbers are 1-844-512-2921 for domestic callers and 1-412-317-6671 for international callers. Please use pin number: 13671687.

About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With $962 million in revenues (2016), NuVasive has an approximate 2,300 person workforce in more than 40 countries serving surgeons, hospitals and patients. For more information, please visit www.nuvasive.com.

Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. Thepotential risks and uncertainties which contribute to the uncertain nature of these statements include, but are not limited to, the risk that NuVasive's revenue or earnings projections may turn out to be inaccurate because of the preliminary nature of the forecasts; the risk of further adjustment to financial results or future financial expectations; unanticipated difficulty in selling products, generating revenue or producing expected profitability; and those other risks and uncertainties more fully described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.


SOURCE NuVasive, Inc.

These press releases may also interest you

at 03:26
A revolution in diabetic foot ulcer treatment and care  Published in The Lancet Diabetes & Endocrinology, the EXPLORER [1] clinical trial is the first clinical study to demonstrate the efficacy of a dressing in the treatment of diabetic foot...

at 03:14
Essity, a leading global hygiene and health company, has today published its Annual and Sustainability Report for 2017, available on www.essity.com. On the company website you will also find a video featuring President and CEO Magnus Groth presenting...

at 03:07
Supplemental Health Care, a leading healthcare workforce solutions company, is proud to earn the "Best Place to Work" award in the large-sized company category by Buffalo Business First, a leading business publication in the region. Supplemental...

at 03:00
ORLANDO, Fla., March 20, 2018 /PRNewswire-PRWeb/ -- It is very common for women to experience acne during pregnancy. It can also be an incredibly frustrating time for soon to be new moms because most women quickly learn that their favorite acne skin...

at 03:00
Omnicell, Inc. , a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will showcase its award-winning platform of solutions at the European Association of Hospital Pharmacists...

at 03:00
SAN ANTONIO, March 20, 2018 /PRNewswire-PRWeb/ -- In a bold effort to advance the practice of plastic surgery, Suresh Koneru, M.D. is the first board-certified plastic surgeon in San Antonio to provide an innovative procedure for patients desiring a...

News published on 5 october 2017 at 16:05 and distributed by: